Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA286705
Max Phase: Preclinical
Molecular Formula: C26H56NO5PS
Molecular Weight: 525.78
Molecule Type: Small molecule
Associated Items:
ID: ALA286705
Max Phase: Preclinical
Molecular Formula: C26H56NO5PS
Molecular Weight: 525.78
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCCCCSCC(COP(=O)([O-])OCC[N+](C)(C)C)OCC
Standard InChI: InChI=1S/C26H56NO5PS/c1-6-8-9-10-11-12-13-14-15-16-17-18-19-20-23-34-25-26(30-7-2)24-32-33(28,29)31-22-21-27(3,4)5/h26H,6-25H2,1-5H3
Standard InChI Key: BXWFBXZXSGLVPU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 525.78 | Molecular Weight (Monoisotopic): 525.3617 | AlogP: 6.81 | #Rotatable Bonds: 26 |
Polar Surface Area: 67.82 | Molecular Species: ACID | HBA: 6 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 1.86 | CX Basic pKa: | CX LogP: 3.31 | CX LogD: 5.33 |
Aromatic Rings: 0 | Heavy Atoms: 34 | QED Weighted: 0.07 | Np Likeness Score: 0.32 |
1. Meyer KL, Marasco CJ, Morris-Natschke SL, Ishaq KS, Piantadosi C.. (1991) In vitro evaluation of phosphocholine and quaternary ammonium containing lipids as novel anti-HIV agents., 34 (4): [PMID:2016713] [10.1021/jm00108a021] |
2. Piantadosi C, Marasco CJ, Morris-Natschke SL, Meyer KL, Gumus F, Surles JR, Ishaq KS, Kucera LS, Iyer N, Wallen CA.. (1991) Synthesis and evaluation of novel ether lipid nucleoside conjugates for anti-HIV-1 activity., 34 (4): [PMID:1901911] [10.1021/jm00108a025] |
3. Morris-Natschke SL, Gumus F, Marasco CJ, Meyer KL, Marx M, Piantadosi C, Layne MD, Modest EJ.. (1993) Synthesis of phosphocholine and quaternary amine ether lipids and evaluation of in vitro antineoplastic activity., 36 (14): [PMID:8336340] [10.1021/jm00066a011] |
4. Morris-Natschke SL, Gumus F, Marasco CJ, Meyer KL, Marx M, Piantadosi C, Layne MD, Modest EJ.. (1993) Synthesis of phosphocholine and quaternary amine ether lipids and evaluation of in vitro antineoplastic activity., 36 (14): [PMID:8336340] [10.1021/jm00066a011] |
5. Morris-Natschke S, Surles JR, Daniel LW, Berens ME, Modest EJ, Piantadosi C.. (1986) Synthesis of sulfur analogues of alkyl lysophospholipid and neoplastic cell growth inhibitory properties., 29 (10): [PMID:3761326] [10.1021/jm00160a055] |
Source(1):